Skip to Content

Newsletter No. 70 -- January 2004

FROM: Cancer Imaging Program, National Cancer Institute, January, 2004.

CIP Web Site: http://cip.cancer.gov/

Announcements

DR. DANIEL SULLIVAN NAMED NEW CHAIR OF THE BECON
Dr. Daniel C. Sullivan of the Cancer Imaging Program has been named the new Chair of the Bioengineering Consortium (BECON) effective January 21. Dr. Sullivan has been very active in BECON activities since the Consortium was established and was the NIH Chair for the BECON Symposium on "Catalyzing Team Science" in June 2003.
URL: http://www.becon.nih.gov/becon.htm

INTERAGENCY COUNCIL ON BIOMEDICAL IMAGING IN ONCOLOGY (ICBIO)
Next Due Date for Requests - February 10 (for March 23 meeting)
The ICBIO convenes technology developers and representatives from the National Cancer Institute (NCI), Food and Drug Administration (FDA), and Centers for Medicare and Medicaid (CMS) to expedite the process of bringing new products to market, to provide advice from a multi-agency perspective on the spectrum of scientific, regulatory, and reimbursement issues related to developing your imaging device or technology. The Request to Present form and further information can be found at http://cancer.gov/dctd/icbio

The Cancer Imaging Program of the NCI requests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof of principle clinical trials. See the web site for details.
URL: http://www3.cancer.gov/bip/dcide.htm

NIH COMMONS
The NIH Commons web site allows all NIH grantee organizations to interact with grants data, to check the status of grant applications, including viewing scores and summary statements when they are ready, and to submit progress reports on line, among a number of functions. Applicants and grants administrators should become familiar with the Commons.
URL: https://commons.era.nih.gov/commons/index.jsp

NEW GRANTS INFORMATION WEBSITE
DHHS has launched a consolidated federal grant website which is searchable and includes an e-mail notification service. Currently it lists more than 800 grant programs, including those sponsored by NIH, NSF, and NASA.
URL: http://grants.gov

Meetings
5TH NATIONAL FORUM ON BIOMEDICAL IMAGING IN ONCOLOGY
January 29-30, 2004, Hyatt Regency Bethesda, Bethesda, MD
URL: http://cancer.gov/dctd/forum

SPIE INTERNATIONAL SYMPOSIUM: MEDICAL IMAGING 2004
14 - 19 February 2004, Town & Country Hotel, San Diego, CA
URL: http://www.spie.org

2004 BIOMEDICAL IMAGING RESEARCH OPPORTUNITIES WORKSHOP (BIROW II) February 25-26, 2004, Bethesda Marriott Hotel, Bethesda, MD. This workshop is the second in a series of five being organized by the AAPM, RSNA, BMES, ARR and AIMBE.
URL: http://www.birow.org

SOCIETY OF INTERVENTIONAL RADIOLOGY 29th Annual Scientific Meeting
Phoenix Civic Plaza, Phoenix, Arizona, March 25 - 30, 2004
ULR: http://www.sirweb.org/annualMeeting/annualMeetingHome.shtml

ACADEMY OF MOLECULAR IMAGING ANNUAL MEETING
2004 AMI Annual Conference, to be held March 28-31, 2004, at the Gaylord Palms Resort and Convention Center in Orlando, Florida.
URL: http://www.ami-imaging.org

CANCER IMAGING 2004: MR, CT & PET
May 23-25, 2004, Sheraton Chicago Hotel & Towers, Chicago, Illinois
URL: http://www.worldclasscme.com

SOCIETY OF NUCLEAR MEDICINE 51st ANNUAL MEETING
June 19-23, 2004, Pennsylvania Convention Center, Philadelphia, PA.
URL: http://www.snm.org/am/

BECON/BISTIC SYMPOSIUM: Informatics for Clinical Decision-making in the 21st Century
June 21-22, 2004, Natcher Auditorium, NIH Campus, Bethesda, MD
URL: http://www.becon.nih.gov/becon_symposia.htm

CARS 2004 COMPUTER ASSISTED RADIOLOGY AND SURGERY
June 23-26, 2004, Hilton & Towers Hotel, Chicago, IL, USA
URL: http://www.cars-int.de/

SEVENTEENTH IEEE SYMPOSIUM ON COMPUTER BASED MEDICAL SYSTEMS (CBMS 2004) June 24-25, 2004, Hotel Four Points by Sheraton, Bethesda, Maryland
URL: http://www.cvial.ttu.edu/Conferences/cbms2004/cbms2004.html

FIRST INTERNATIONAL SYMPOSIUM ON CANCER METASTASIS AND THE LYMPHOVASCULAR SYSTEM: THE BASIS FOR RATIONAL THERAPY
July 8-10, 2004, San Francisco, CA, USA

THIRD ANNUAL MEETING OF THE SOCIETY FOR MOLECULAR IMAGING
September 9-12, 2004, Adam's Mark Hotel, St. Louis, MO
URL: http://www.molecularimaging.org/meeting3/home04.php3

NIH
1. IN VIVO CANCER IMAGING EXPLORATORY/DEVELOPMENTAL GRANTS (R21s) (NCI) (PA-04-045)
Application Receipt Dates: February 1, June 1, and October 1
The Cancer Imaging Program (CIP) solicits exploratory/developmental (R21) applications that articulate exploratory/developmental research focused on in vivo cancer imaging. The R21 mechanism will provide investigators at all career levels with a defined level of funding adequate for the initial development and/or feasibility testing of high impact concepts.
URL: http://grants1.nih.gov/grants/guide/pa-files/PA-04-045.html

2. CLINICAL CANCER THERAPY AND PREVENTION RESEARCH (NCI) (PA-04-046)
The NCI is seeking R01 applications to conduct translational, clinical, therapeutic, and preventive studies/trials of neoplastic diseases in humans and encourages clinical researchers to collaborate with basic scientists to translate insights in cancer biology and the development of new anti-cancer agents into innovative cancer intervention studies/trials.
URL: http://grants.nih.gov/grants/guide/pa-files/PA-04-046.html

3. NIH ROADMAP
The NIH Roadmap is an integrated vision to deepen our understanding of biology, stimulate interdisciplinary research teams, and reshape clinical research to accelerate medical discovery and improve people's health. Most of the initiatives will begin in FY 2004. Other initiatives will start in FY 2005 and beyond, depending upon the budget and other emerging needs. The three NIH Roadmap themes are as follows: new pathways to discovery, research teams of the future, and re-engineering the clinical research Enterprise.
URL: http://nihroadmap.nih.gov/

ROADMAP ADDENDUM: NATIONAL TECHNOLOGY CENTERS FOR NETWORKS AND PATHWAYS
PRE-APPLICATION MEETING RFA-RM-04-005 (ROADMAP)(NOT-RM-04-005)
NIH has scheduled an informational pre-application meeting at which program staff will discuss the goals and objectives for National Technology Centers for Networks and Pathways described in RFA-RM-04-005 (at http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-04-005.html) and answer questions. All prospective applicants are invited to participate.
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-RM-04-005.html

4. NCI TRANSITION CAREER DEVELOPMENT AWARD (PAR-04-040)
The purpose of the NCI Transition Career Development (K22) Award is to facilitate the transition of investigators from the mentored stage of career development in academic cancer research to the independent stage. Postdoctoral individuals (who are not required to have a sponsoring institution at the time of application) transitioning into their first independent position, and investigators within the first two years of their first independent cancer research position are eligible.
URL: http://grants1.nih.gov/grants/guide/pa-files/PAR-04-040.html

5. NCI COMPETING CONTINUATION SBIR/STTR PHASE II GRANTS FOR CANCER DIAGNOSIS, PREVENTION AND TREATMENT (PA-04-047)
LETTER OF INTENT RECEIPT DATES: March 1, July 1, November 1 of each year
APPLICATION RECEIPT DATE(S): Standard SBIR/STTR deadlines (April 1, August 1, and December 1).
NCI is soliciting grant applications for the competing continuation of previously funded Phase II SBIR/STTR grants that propose to continue the process of developing products for commercialization that ultimately require: 1) approval of a Federal regulatory agency and 2) clinical evaluation up to "proof of principle" demonstration, generally only through a Phase II clinical trial. Such products include, but are not limited to: … radioligands, biomarkers, medical implants or devices, imaging protocols proposed for clinical use, new software for instrument performance, etc.
URL: http://grants.nih.gov/grants/guide/pa-files/PA-04-047.html

6. NCI INNOVATIVE TECHNOLOGIES FOR MOLECULAR ANALYSIS OF CANCER (CA-05-002)
Letter of Intent: January 16, 2004; May 17, 2004; September 17, 2004
Receipt: February 17, 2004; June 17, 2004; October 18, 2004
The NCI invites applications for research projects proposing the development of highly innovative cancer relevant technologies, encompassing methods and tools that enable research, including, but not limited to, instrumentation, techniques, and devices. Technology is distinct from resources such as databases, reagents, and tissue repositories. This initiative will employ separate discovery (R21) and development (R33) awarding mechanisms. The R21 application will emphasize the high risk, high innovation feasibility phase and potential impact. The development (R33) phase application will have to contain proof of the feasibility of the proposed technology.
URL: http://grants2.nih.gov/grants/guide/rfa-files/RFA-CA-05-002.html
SBIR/STTR Version (RFA-CA-05-006).
URL http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-05-006.html


7. NCI APPLICATION OF EMERGING TECHNOLOGIES FOR CANCER RESEARCH (CA-05-003)
Letter of Intent: January 16, 2004; May 17, 2004; September 17, 2004
Receipt: February 17, 2004; June 17, 2004; October 18, 2004
The NCI invites applications for research projects to evaluate the usefulness of emerging technologies that are ready for initial application to clinical or biological questions in cancer research. Projects should be designed to demonstrate that the technology is robust and yields reproducible measurements, as well as be designed to gather preliminary data to support the use of the technology in a future project(s) with a clinical or biological focus. This RFA will use NIH R21/R33 Phased Innovation Award and the R33 Exploratory/Developmental Phase II award mechanisms.
URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-05-003.html
SBIR/STTR Version (RFA-CA-05-007).
URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-05-007.html

8. SMALL BUSINESS INNOVATION RESEARCH (SBIR) AND SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) GRANT PROGRAMS (NIH, FDA, CDC) (NOT-OD-04-016)
The purpose of this notice is to (1) announce the issuance of the solicitation of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer STTR) grant applications (PHS 2004-2) and (2) inform the public about the opportunities that the SBIR/STTR programs offer to small business concerns.
URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-04-016.html

_______________________
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.

If you wish to remain on the list, no action is necessary. If you wish to be added to the list (or removed from it), please contact Ms. Johnnie Smith by return e-mail (js95x@nih.gov).

Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
EPN, Room 6000 - MSC-7412
6130 Executive Boulevard
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507